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AbstractMesenchymal stem cells (MSCs) are multipotent stromal cells that have the capacity to regenerate tissue damage. However, they have several limitations. MSC-CM as a new approach treatment is widely used to solve the limitation 
of MSC in wound healing. The aim of this study was to evaluate the effectiveness of TNF-α-activated MSC-CM topical gel compare to topical-subcutaneous injection combination on wound healing acceleration. This study was conducted between April–August 2018 at the Stem Cell and Cancer Research Laboratory (SCCR), Faculty of Medicine, Sultan Agung Islamic University, Semarang. Experimental post-test only control group design was performed by involving 36 animal models randomly divided into six groups; T1, T2 (MSC-CM in topical gel 100 
μL; 200 μL); ST1, ST2 (MSC-CM in subcutaneous injection: topical gel= 80 μL:20 μL; 160 μL:40 μL); CT (200 
μL medium free TNF-α); CST (PBS in subcutaneous injection: topical gel= 160 μL:40 μL). The measurement of 
PDGF level on day 3 and 6 was conducted using ELISA assay while the fibroblast density was analyzed by light 
microcopy.  It was found that there was was a significant increase in PDGF and fibroblast density on day 6 in the topical group when compared to the combination group (p<0.05). It is concluded that the MSC-CM topical gel is more effective than combination of topical-subcutaneous injection. 
Key words: Combination, fibroblast, MSC-CM, PDGF, subcutaneous MSC-CM, topical MSC-CM
MSC-CM Topikal yang diaktivasi TNF-α Efektif dalam Peningkatan Level 
PDGF, Densitas Fibroblast, dan Mempercepat Penyembuhan Luka 
dibanding dengan Kombinasi Injeksi Subkutan
Abstrak 
Mesenchymal stem cells (MSCs) merupakan sel stroma multipoten yang memiliki kemampuan untuk meregenerasi kerusakan jaringan. Namun, MSC memiliki beberapa keterbatasan. MSC-CM sebagai terapi pendekatan baru digunakan untuk mengatasi keterbatasan MSC dalam penyembuhan luka. Tujuan penelitian ini adalah menilai 
efektivitas MSC-CM topikal yang diaktvasi TNF-α dibanding dengan kombinasi topikal-injeksi subkutan pada percepatan penyembuhan luka. Penelitian ini dilaksanakan pada bulan April–Agustus 2018 di Laboratorium 
Stem Cell and Cancer Research (SCCR), Fakultas Kedokteran, Universitas Islam Sultan Agung, Semarang. Penelitian menggunakan eksperimen laboratorium dengan rancangan post-test only control group, menggunakan 36 tikus galur wistar yang dibagi secara acak menjadi 6 kelompok; T1, T2 (MSC-CM gel topikal 100 μL; 200 μL); ST1, ST2 
(MSC-CM injeksi subkutan: gel topikal= 80 μL:20 μL; 160 μL:40 μL); CT (200 μL medium tanpa TNF-α); CST (PBS 
injeksi subkutan : gel topikal= 160 μL :40 μL). Pengukuran kadar PDGF pada hari ke-3 dan ke-6 mengunakan 
ELISA, sedangkan jumlah fibroblas dilihat mengunakan mikroskop cahaya. Hasil penelitian ini menunjukkan 
peningkatan kadar PDGF dan jumlah fibroblas yang signifikan di hari ke-6 pada MSC-CM gel topical dibanding dengan kombinasi topical-injeksi subukutan (p <0,05). Simpulan penelitian ini adalah pemberian MSC-CM secara topikal lebih efektif dibanding dengan kombinasi topikal-injeksi subkutan. 
Kata kunci: Konditional medium, MSC-CM topikal, MSC-CM kombinasi, PDGF, Fibroblas
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Introduction
Mesenchymal stem cells (MSCs) are defined as multipotent stromal cells that have a capacity 
to regulate the inflammatory response and regenerate tissue damage.1–3 They may be isolated from umbilical cord, bone marrow, and adipose. Based on International Society for 
Cellular Therapy (ISCT), MSCs have criteria: adherence to plastic culture under standard 
medium conditions; may express CD90, CD73, CD105, and lack of CD14, CD45, CD34, CD11b, CD31 and HLA-DR expression; may differentiate into osteocytes, chondrocytes, and adipocytes.4 Umbilical cord-mesenchymal stem cells (UC-MSCs) becomes an alternative source of MSCs because they can be noninvasively collected and expanded, even cryopreserved.5 However, MSCs have several limitations such as complexity technique and low survivability of cells after being transplanted in a target area. Therefore, developing an alternative approach is needed such as using soluble molecules released by MSCs.Previous studies reported that MSCs under 
inflammation produce several anti-inflammatory 
cytokines such as IL-10 and TGF-β in addition to molecule proliferation, particularly platelet-derived growth factor (PDGF), and vascular endothelia growth factor (VEGF) into medium culture known as MSC-conditioned medium (MSC-CM).6,7 TNF-α-activated MSCs may secrete large quantities of soluble molecule for accelerating the regeneration of tissue damage.8 Platelet-derived growth factor is one of several growth factors which can control the growth, differentiation, and activation of diverse cell types by stimulating chemotaxis, angiogenesis, 
and fibroblasts proliferation.9–11 These facts suggest that the soluble molecule secreted by MSCs as CM might be one of effective ways in wound healing treatment.Mesenchymal Stem Cell Conditioned Media (MSC-CM) has been widely used to accelerate wound healing. From several studies, it was reported that the use of MSC-CM topical is effective. Previous study reported that MSC-CM topical contains IL-8 that increase the accumulation of macrophage, stimulates angiogenesis, and increases cell proliferation by topical application on cutaneous wound healing.(12) Mesenchymal Stem Cell Conditioned Media (MSC-CM) applied by subcutaneous injection may accelerate wound healing.13 In other side, topical- subcutaneous injection combination can enhance macrophage migration, keratinocytes, 
and endothelial cell.14 These facts show that MSC-CM is effective to enhance wound healing. However, the best technique to accelerate wound healing remains unclear. The aim of this study was to evaluate the effectiveness of MSC-CM topical gel compared to topical-subcutaneous injection combination on wound healing acceleration. 
MethodsThis study was conducted from April to August 2018 in Stem Cell and Cancer Research Laboratory (SCCR), Faculty of Medicine, Sultan Agung Islamic University, Semarang. All activities were approved and in accordance with the Bioethics Commission (Komisi Bioetik), Faculty of Medicine, Universitas Islam Sultan Agung, 
Semarang No. 158/III/2017/Komisi Bioetik.The isolation of MSCs from umbilical cord of 19 days pregnancy of female rat was performed. After the umbilicus was washed using PBS, the blood vessels were removed then cut into lengths of 2-5 mm using a sterile scalpel. The sections 
were then distributed evenly on T25 flask. The 
medium used was Dulbecco’s modified Eagle’s medium (DMEM) (Sigma-Aldrich, St. Louis, 
MO) supplemented with 10% PBS, 100 IU/ml 
penicillin/streptomycin (GIBCO, Invitrogen), 
then incubated at 37 °C with 5% CO2. The medium was refreshed every 3 days.The analysis of MSCs-like surface 
antigens wasperfomed by flow cytometric analysis at the fourth passage. The cells were subsequently incubated in the dark with 
fluorescein isothiocyanate (FITC)-conjugated, allophycocyanin (APC)-conjugated, or phycoerythrin (PE)-conjugated monoclonal 
antibodies, including CD105, CD90, and CD73. FITC-, APC-, and PE-conjugated isotypes were used as negative controls. The analysis was performed using BD PharmingenTM (BD 
Bioscience, Franklin Lakes, NJ, USA) at 4 °C for 30 minutes. The cells were washed twice with 
1% BSA/PBS, resuspended in 200 µL 1% BSA/
PBS, and analyzed by a flow cytometer (BD Biosciences, San Jose, CA, USA).The MSCs were grown in plate at densities of 1x104 cells/well cultured in DMEM  supplemented with osteogenic induction medium containing 
10 mmol/L β-glycerophosphate, 10-7 mol/L/0.1 
μM dexamethasone, 50μmol/L ascorbate-2-phosphate (Sigma-Aldrich, Louis St, MO), and 
10 % fetal bovine serum (FBS). To find calcium 
deposits, the cells were rinsed in PBS and fixed 
with cold 70% ethanol (v/v) for 1 hour at room 
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Figure 1  Flow Cytometry Analysis of MSCs Positive Markers. The Characteristic of UC-MSCs   
    Expressed CD73, CD90, and CD105
temperature, then rinsed three times with double distilled water. The osteogenic differentiation 
was analyzed by Alizarin Red staining by added 1 
mL 2% Alizarin Red solution (w/v) (pH 4.1–4.3) to the cells, incubated for 30 minutes at room temperature, then rinsed four times in double distilled water. The MSCs (1x104 cells/well) were cultured in DMEM medium (Sigma-Aldrich, Louis St, MO), 
supplemented with 10 ng/mL recombinant 
TNF-α (BioLegend, San Diego, CA) on a 24-well plate. The cells were then incubated for 24 hours 
at 37 °C with 5% CO2. After 24 hour incubation, MSC-CM was collected by centrifuging the cells at 
2,000 rpm for 7 minutes to remove cell debris. In addition, for vehicle group, the DMEM serum-free medium was similarly processed. Conditional medium gel was made by supplemented base gel with the conditional medium.Experimental post–test only control groups design was performed involving 36 animals 
model male Wistar rat weighted 250g that were 
housed at a constant temperature (22 ± 2°C) 
and 60% relative humidity, with 12:12-hour 
light-dark cycle. The rats were anesthetized 
by isofluorane inhalation, then the dorsal hair was shaved and cleaned with tincture of iodine. One full-thickness circular 6 mm biopsy punch excision was done for each rat. The animals were randomly divided into six groups; T1, T2 
(MSC-CM in topical gel 100μL; 200μL); ST1, ST2 
(MSC-CM in subcutaneous injection: topical gel = 
80μL: 20μL; 160μL: 40 μL); CT (200 μL medium 
free TNF-α); CST (PBS in subcutaneous injection 
: topical gel = 160μL: 40 μL). The measurement of PDGF levels on day 3 and 6 using ELISA assay 
was performed while the fibroblast density was 
analyzed by light microcopy. In vivo analysis was done using rat’s serum 
sample to check PDGF levels. Platelet derived growth factor (PDGF) assay by means of an ELISA kit was performed at room temperature according to the manufacturer’s instructions 
(Fine Test, Wuhan, China). The serum was measured in day 3 and day 6 according to a standard curve constructed for each assay. The colorimetric absorbance as the PDGF 
concentrations (pg/mL) was analyzed at a wavelength of 450 nm using a microplate reader on day 3 and 6 of the experiment.
The wounded tissues were fixed in formalin 
then blocked in paraffin. Horizontal sections were 
taken from each paraffin block using microtome. Hematoxylin and eosin (H-E) staining was 
performed by dissolving the paraffin substances 
first with Xylene for 1 minute. Hereinafter, each 
group of fibroblast was evaluated by pathologist. The comparison that was more than two groups used ANOVA, followed by Post Hoc 
Fisher’s LSD. A 𝑃 value of <0.05 was considered
significant. All analysis was performed with SPSS 16.0.
Results
The characteristics of MSCs after flow cytometry 
analysis were shown in figure 1. The cells were cultured for 3–4 passages before used for this study. The MSCs positively expressed 99.2% of 
CD73, 96,7% of CD90, and 67,1% of CD105. The 
purified cells showed fusiform appearance and 
became 80% confluent after 5–7 days in culture and were regularly passaged. After 21 day incubation with osteogenic-differentiating medium, the MSCs were stained 
with Alizarin Red staining to analyze osteogenic differentiation. The MSCs were able to be 
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Figure 2  (a) The Morphology of UC-MSC-Like From the In Vitro Culture Showed Polygonal Shape  
    and Fibroblast-Like Cells, with 40x Magnification, (b) The Osteogenic Differentiation with  
    Alizarin Red Staining Appears Red Color in MSCs
Figure 3 Effects of MSC-CM Activated TNF-α on PDGF Level and Fibroblast Density (A) PDGF Levels  
   on Day 3 and 6 (B) Fibroblast Density on Day 6. (CT= 200 μL Medium Free TNF-α; CST=  
   160 μL Subcutaneous Injection, 40 μL Topical Gel PBS; T1= 100μL MSC-CM Topical Gel;  
   T2= 200μL MSC-CM Topical Gel; ST1= 80 μL Subcutaneous Injection, 20 μL Topical Gel  
    MSC-CM; ST2= 160 μL Subcutaneous Injection, 40 μL Topical Gel MSC-CM)
A B
Figure 4. The Histological Appearance of Fibroblast. (A) Fibroblast Day 3 and (B) Fibroblast Day 6
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differentiated into osteogenic cells indicated by a 
red color from Alizarin red staining (Figure 2b).The level of PDGF was measured using ELISA with blood sample taken from ophthalmic vein of 
rats, and then the fibroblast was measured using 
HE staining. There were significant differences between topical gel group compared to topical-subcutaneous injection combination in PDGF 
levels and fibroblast density on day 6 (p<0.05). 
The best PDGF levels and fibroblast density were 
found on day 6 in T2 group 542.42±4.15pg/mL 
and 22.2±0.83x 105cell/mL respectively.. There 
was no significant difference of PDGF levels on day 3 between topical gel (T2) and topical-subcutaneous injection combination group (ST1) (Figure 3). These results were supported 
with the appearance of fibroblast analysis using light microscope.
DiscussionCutaneous non-healing wounds have been a subject of concern to the medical problem. Previous study reported that MSC-CM has been widely used to accelerate wound healing by topical application that has been reported effective.13,14 In other study, it was demonstrated that the topical-subcutaneous injection combination may accelerate wound healing, however the subcutaneous injection is an invasive technique. These facts show that subcutaneous injection and topical are the effective techniques of MSC-CM application for accelerating wound healing. Nonetheless, the effectiveness of both techniques remains unclear. In this study, we used full-thickness wound animal model, then compared the effectiveness of topical gel to topical-subcutaneous injection 
combination using TNF-α activated MSC-CM like previous study.13,14Theresult of the study showed that there was 
a significant increase in PDGF on day 6 in topical 
compared to combination group. We suggest that the wound healing process was accelerated to the proliferation stage in topical gel group. Meanwhile, the combination group remained 
in inflammatory process due to invasive subcutaneous injection. On the other hand, there 
was no significant increase between topical and combination group on day 3 due to the wound 
healing process that was still in inflammation stage. The soluble molecule inside the MSC-CM such as interleukin-10 (IL-10), TGF-b may 
inhibit inflammation process leading to the shift 
of inflammation to proliferation stage marked by 
the increase of PDGF levels.15 These are in line with previous study reporting that the PDGF may activate and induce cell proliferation particularly 
fibroblast by up-regulating ERK pathway.16,17
The activated fibroblast correlates with wound healing as found in our study at Figure 4.
There was a significant increase in fibroblast density on day 6 in topical compared to combination group. These facts showed that the wound healing process accelerated the 
shift of inflammation to the proliferation stage at topical to combination group. There was an 
ongoing inflammation process on combination group as a result of invasive subcutaneous injection, whereas the proliferation stage was gradually running on topical group. This is in accordance with previous study reporting that there are migration and completely covered spaces of wound at scratch wound assays post CM exposure.18 This is in line with another study reporting that MSC-CM accelerates wound 
closure by stimulating the increase of fibroblast and keratinocyte cells migration, rather than on cell proliferation or survival.19The expression of PDGF initiates the 
activity of fibroblast by up-regulating ERK1/2 pathway, which induces the activation of MAPK leading to the expression of c-Fos protein and the transcription of various growth factors, particularly for regeneration cause in wound closure.16The conclusion is that the MSC-CM topical gel is more effective than topical-subcutaneous injection combination. The limitation of this study was the soluble molecule inside the MSC-
CM and fibroblast in remodeling phase were not measured. 
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